TOI - Deerfield Management to invest $110M in The Oncology Institute
- Investment funds affiliated with Deerfield Management will invest $110M in The Oncology Institute ( NASDAQ: TOI ), the cancer-care community group said on Tuesday.
- As per the deal, TOI has agreed to issue Deerfield $110M aggregate principal amount of 4% secured senior convertible notes.
- TOI said the convertible notes have an initial conversion price of $8.567, which represents a 30% premium to TOI's closing price on Monday.
- "This investment will provide TOI with important growth capital to accelerate our expansion into new markets with our differentiated value-based approach to oncology," said TOI CEO Brad Hively.
- The Oncology Institute ( TOI ) separately announced Q2 results . The company swung to a Q2 loss per share from profit last year. It also kept its FY 2022 revenue guidance unchanged at $270M to $310M.
- Shares of TOI gained 8.6% to $7.20 in after hours.
For further details see:
Deerfield Management to invest $110M in The Oncology Institute